Additive effect of beta-adrenergic blockers in combination with vasodilators in lowering blood pressure
- PMID: 14626
- DOI: 10.1111/j.1445-5994.1976.tb03340.x
Additive effect of beta-adrenergic blockers in combination with vasodilators in lowering blood pressure
Abstract
Complications of hypertension are by far the greatese preventable public health problem in many of the developed countries of the world. Pharmacologic interventions which primarily involve drug interactions are the generally available and effective means of preventing or delaying these hypertensive complications. Mechanisms of beneficial antihypertensive drug interactions involve simultaneous reduction or control of blood volume (diuretic agents) and decrease of peripheral resistance. Reduction of peripheral resistance without producing intolerable side effects has recetnly been achieved by a complex drug interaction. This interaction involves simultaneous vasodilation and inhibition by beta-adrenergic blocking agents of reflex activation of the renin-angiotensin axis. Clonidine, by effects similar to propranolol, can substitute for propranolol in some patients, or add to the beneficial effects of this important drug interaction.
Similar articles
-
Clonidine and the vasodilating beta blocker antihypertensive drug interaction.Clin Pharmacol Ther. 1977 Aug;22(2):164-71. doi: 10.1002/cpt1977222164. Clin Pharmacol Ther. 1977. PMID: 18312
-
Propranolol and newer antihypertensive drugs in the management of hypertension.Adv Cardiol. 1979;26:38-43. doi: 10.1159/000402387. Adv Cardiol. 1979. PMID: 420060
-
Modern concepts in the drug treatment of arterial hypertension.Int J Clin Pharmacol Ther Toxicol. 1980 Sep;18(9):412-9. Int J Clin Pharmacol Ther Toxicol. 1980. PMID: 6108920
-
The pharmacologic basis of antihypertensive therapy: The role of vasodilator drugs.Prog Cardiovasc Dis. 1974 Sep-Oct;17(2):99-113. doi: 10.1016/0033-0620(74)90025-5. Prog Cardiovasc Dis. 1974. PMID: 4153137 Review. No abstract available.
-
Vasodilators in hypertension--a review with special emphasis on the combined use of vasodilators and beta-adrenoceptor blockers.Int J Clin Pharmacol Ther Toxicol. 1985 Aug;23(8):411-23. Int J Clin Pharmacol Ther Toxicol. 1985. PMID: 2864319 Review.
Cited by
-
The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.Br J Clin Pharmacol. 1978 May;5(5):379-99. doi: 10.1111/j.1365-2125.1978.tb01644.x. Br J Clin Pharmacol. 1978. PMID: 26370 Free PMC article. Review.
-
Propranolol and beta-adrenergic receptor blocking drugs in the treatment of hypertension.Br J Clin Pharmacol. 1982 Jan;13(1):51-60. doi: 10.1111/j.1365-2125.1982.tb01336.x. Br J Clin Pharmacol. 1982. PMID: 6121573 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources